Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc Company Profile - GlobalData
Puma Biotechnology, Inc. (PBYI): history, ownership, mission, how it works & makes money
Marcus Morreale - Puma Biotechnology, Inc. | LinkedIn
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up
Puma Biotechnology begins Phase II trial of lung cancer drug
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
EX-99.1
Puma Biotech anti-HER2 breast cancer drug approved in China - BioTuesdays
Is This Low-Priced Biotech Stock a Hidden Gem? - TheStreet's Real Money Pro
Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
Puma Biotechnology, Inc. (PBYI) BCG Matrix Analysis
Puma Biotechnology: Cheap But Quite Risky (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech's (PBYI) Breast Cancer Drug Nerlynx Aids Growth
pbyi-10k_20171231.htm
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates | Nasdaq
Reasons to Add Puma (PBYI) Stock to Your Portfolio Right Now — TradingView News
Jon Mead - Puma Biotechnology, Inc. | LinkedIn
Reasons to Add Puma (PBYI) Stock to Your Portfolio Right Now | Nasdaq
Puma Biotechnology: Finding Bullish Indications At The End Of 2019 (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
